[YMAB] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
07-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -13.15%
YoY- -64.30%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 20,251 10,486 5,383 0 0 0 0 -
PBT -6,390 -28,068 33,413 -26,179 -15,934 -7,483 -3,041 13.16%
Tax -1,293 373 338 0 -19 -7,479 23 -
NP -5,097 -28,441 33,413 -26,179 -15,934 -7,483 -3,041 8.98%
Tax Rate - - -1.01% - - - - -
Total Cost 25,348 38,927 -28,030 26,179 15,934 7,483 3,041 42.36%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -25.17 -271.23 620.71 0.00 0.00 0.00 0.00 -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.12 -0.65 0.80 -0.66 -0.47 -0.22 -0.17 -5.63%
EPS Diluted -0.12 -0.65 0.75 -0.66 -0.47 -0.22 -0.17 -5.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.